IMR Press / FBE / Special Issues / antimicrobial_resistance

Antimicrobial Resistance

Submission deadline: 31 December 2022
Special Issue Editor
Jinwei Zhang, PhD
University of Exeter Medical School, Exeter, UK
Interests: antimicrobial resistance; disease biology; drug discovery; biotechnology
Special Issue Information

Dear Colleagues,

Antimicrobial resistance (AMR) represents a threat to global health because the misuse and overuse of antibiotics results in the development of drug-resistant pathogens. According to the World Health Organization (WHO), AMR is one of the top 10 global public health threats to humanity, with a significant cost to the economy. The development of effective antimicrobials is therefore important for the success of modern medicine in treating infections, including during major surgery, cancer chemotherapy, and various human diseases.

For example, stroke is a complication in 15% to 25% of bacterial meningitis cases and contributes to the substantial neurologic morbidity associated with this disease. The incidence of stroke depends on the specific pathogen, with a higher incidence from Streptococcus pneumoniae [36%] and a lower incidence with Neisseria meningitides [9%]. Therefore, the development of new drug therapies for these diseases is very difficult and would have a major impact on the patient's quality of life.

This Special Issue welcomes the submission of original research and review articles that shed light on the current situation, mechanisms, epidemiology, detection methods and clinical treatments for AMR. Potential topics include but are not limited to the following:

  • The identification of new molecular mechanisms for AMR
  • Discovering new ways to prevent and treat drug-resistant bacterial infections
  • The emergence and spread of drug-resistant pathogens
  • The development of new antibiotics for the treatment of drug-resistant pathogens
  • The provision of specific guidelines for preventing AMR

Our best regards,  
Jinwei Zhang
Guest Editor

antimicrobial resistance
drug-resistant pathogens
resistance mechanisms
new treatments
therapeutic targets
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.

Back to top